Your browser doesn't support javascript.
loading
Early intervention for children at risk of visual processing dysfunctions from 1 year of age: a randomized controlled trial protocol.
Kooiker, Marlou J G; van der Linden, Yoni; van Dijk, Jenneke; van der Zee, Ymie J; Swarte, Renate M C; Smit, Liesbeth S; van der Steen-Kant, Sanny; Loudon, Sjoukje E; Reiss, Irwin K M; Kuyper, Kees; Pel, Johan J M; van der Steen, Johannes.
Affiliation
  • Kooiker MJG; Department of Neuroscience, Erasmus Medical Center, PO Box 2040, 3000, CA, Rotterdam, The Netherlands. m.kooiker@erasmusmc.nl.
  • van der Linden Y; Royal Dutch Visio, Center of Expertise for Blind and Partially Sighted People, the Hague, The Netherlands.
  • van Dijk J; Royal Dutch Visio, Center of Expertise for Blind and Partially Sighted People, the Hague, The Netherlands.
  • van der Zee YJ; Royal Dutch Visio, Center of Expertise for Blind and Partially Sighted People, Rotterdam, The Netherlands.
  • Swarte RMC; Department of Pediatrics, Division of Neonatology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Smit LS; Department of Pediatrics, Division of Neonatology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • van der Steen-Kant S; Department of Neurology, Division of Pediatric Neurology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Loudon SE; Royal Dutch Visio, Center of Expertise for Blind and Partially Sighted People, Huizen, The Netherlands.
  • Reiss IKM; Department of Pediatric Ophthalmology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Kuyper K; Department of Pediatrics, Division of Neonatology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Pel JJM; Royal Dutch Visio, Center of Expertise for Blind and Partially Sighted People, Rotterdam, The Netherlands.
  • van der Steen J; Department of Neuroscience, Erasmus Medical Center, PO Box 2040, 3000, CA, Rotterdam, The Netherlands.
Trials ; 21(1): 44, 2020 Jan 08.
Article de En | MEDLINE | ID: mdl-31915035
ABSTRACT

BACKGROUND:

An increasing number of children are suffering from brain damage-related visual processing dysfunctions (VPD). There is currently a lack of evidence-based intervention methods that can be used early in development. We developed a visual intervention protocol suitable from 1 year of age. The protocol is structured, comprehensive and individually adaptive, and is paired with quantitative outcome assessments. Our aim is to investigate the effectiveness of this first visual intervention program for young children with (a risk of) VPD.

METHODS:

This is a single-blind, placebo-controlled trial that is embedded within standard clinical care. The study population consists of 100 children born very or extremely preterm (< 30 weeks) at 1 year of corrected age (CA), of whom 50% are expected to have VPD. First, children undergo a visual screening at 1 year CA. If they are classified as being at risk of VPD, they are referred to standard care, which involves an ophthalmic and visual function assessment and a (newly developed) visual intervention program. This program consists of a general protocol (standardized and similar for all children) and a supplement protocol (adapted to the specific needs of the child). Children are randomly allocated to an intervention group (starting upon inclusion at 1 year CA) or a control group (postponed starting at 2 years CA). The control group will receive a placebo treatment. The effectiveness of early visual intervention will be examined with follow-up visual and neurocognitive assessments after 1 year (upon completion of the direct intervention) and after 2 years (upon completion of the postponed intervention).

DISCUSSION:

Through this randomized controlled trial we will establish the effectiveness of a new and early visual intervention program. Combining a general and supplement protocol enables both structured comparisons between participants and groups, and custom habilitation that is tailored to a child's specific needs. The design ensures that all included children will benefit from participation by advancing the age at which they start receiving an intervention. We expect results to be applicable to the overall population of children with (a risk of) VPD early in life. TRIAL REGISTRATION Netherlands Trial Register NTR6952. Registered 19 January 2018.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Troubles de la perception / Troubles de la vision / Perception visuelle / Naissance prématurée / Troubles du développement neurologique Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limites: Child, preschool / Female / Humans / Infant / Male Pays/Région comme sujet: Europa Langue: En Journal: Trials Sujet du journal: MEDICINA / TERAPEUTICA Année: 2020 Type de document: Article Pays d'affiliation: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Troubles de la perception / Troubles de la vision / Perception visuelle / Naissance prématurée / Troubles du développement neurologique Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limites: Child, preschool / Female / Humans / Infant / Male Pays/Région comme sujet: Europa Langue: En Journal: Trials Sujet du journal: MEDICINA / TERAPEUTICA Année: 2020 Type de document: Article Pays d'affiliation: Pays-Bas